Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/18/2007 | CA2299586C Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
09/18/2007 | CA2216919C Nanospheres comprising a biocompatible polysaccharide |
09/18/2007 | CA2181568C Use of interleukin-12 to prevent graft versus host disease |
09/18/2007 | CA2164193C Intravaginal preparation containing physiologically active peptide |
09/18/2007 | CA2125158C Proteolytic mixture containing escharase and method of isolating same |
09/18/2007 | CA2032859C Method of reducing or preventing adverse effect of steroid therapy and compositions therefor |
09/16/2007 | CA2539902A1 Method of enhancing degradation of chitin |
09/14/2007 | CA2577352A1 Canine and equine collagen joint health supplement |
09/13/2007 | WO2007103934A2 Compositions and methods of use of ritonavir for treating hcv |
09/13/2007 | WO2007103775A2 Biomaterials having nanoscale layers and coatings |
09/13/2007 | WO2007103765A2 Treatment with cyclosporin a |
09/13/2007 | WO2007103543A2 The role of the mk2 pathway in wound repair |
09/13/2007 | WO2007103523A2 Antioxidant protein, compositions, and methods of use |
09/13/2007 | WO2007103515A2 Unstructured recombinant polymers and uses thereof |
09/13/2007 | WO2007103455A2 Genetic packages and uses thereof |
09/13/2007 | WO2007103368A2 Methods for regulating inflammatory mediators and peptides useful therein |
09/13/2007 | WO2007103364A2 Targeted drug delivery |
09/13/2007 | WO2007103182A2 Compostions and methods for administering gdnf ligand family proteins |
09/13/2007 | WO2007103009A2 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES |
09/13/2007 | WO2007102936A2 Polynucleotides for production of farnesyl dibenzodiazepinones |
09/13/2007 | WO2007102812A2 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells |
09/13/2007 | WO2007102797A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
09/13/2007 | WO2007102735A1 Use of peptides for the control of radiation injury |
09/13/2007 | WO2007102562A1 Novel antithrombotic agent |
09/13/2007 | WO2007102410A1 Novel use of rage polypeptide |
09/13/2007 | WO2007102365A1 Anti-viral peptide and use thereof |
09/13/2007 | WO2007102162A2 Regulating stem cells |
09/13/2007 | WO2007101988A2 Use of tsg-6 for treating bone diseases |
09/13/2007 | WO2007101949A2 Human interferon-gamma (infgamma) variants |
09/13/2007 | WO2007101915A1 Method for enhancing cyclodextrin complexation |
09/13/2007 | WO2007101882A1 Tropolone- and hydroxybenzene-substituted oligopeptides for depigmentation |
09/13/2007 | WO2007101681A1 Highly phosphorylated and sulfated recombinant factor ix |
09/13/2007 | WO2007101370A1 Use of glycoconjugate chb in preparing a medicament for preventing or treating flu or poultry influenza |
09/13/2007 | WO2007087457A3 Combination therapy for the treatment of neovascular disorders |
09/13/2007 | WO2007087367A9 Methods and compositions for modulating the mobilization of stem cells |
09/13/2007 | WO2007087241A3 Treatment of ischemic disease using thrombopoietin |
09/13/2007 | WO2007086932A3 Prostate stem cell antigen vaccines and uses thereof |
09/13/2007 | WO2007083146A3 The treatment of cognitive and psychotic disorders |
09/13/2007 | WO2007079977A3 Nutraceutical compositions comprising tripeptides |
09/13/2007 | WO2007079460A3 Design of cxc chemokine analogs for the treatment of human diseases |
09/13/2007 | WO2007073706A3 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
09/13/2007 | WO2007071850A3 Inhibition of the anti-fviii immune response |
09/13/2007 | WO2007071248A8 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
09/13/2007 | WO2007065156B1 Pharmaceutical formulation for increased epithelial permeability of glucose-regulating peptide |
09/13/2007 | WO2007065128A3 Human alpha-defensins inhibit interleukin-1beta release |
09/13/2007 | WO2007062249A3 Potent compstatin analogs |
09/13/2007 | WO2007062188A3 Activin-actriia antagonists and uses for promoting bone growth |
09/13/2007 | WO2007050052A3 Process for treatment of protein samples |
09/13/2007 | WO2007041438A3 Compositions comprising glycerophosphodiester phosphodiesterase (gde) and uses thereof |
09/13/2007 | WO2007038386A3 Method for enhancing immune responses in mammals |
09/13/2007 | WO2007038169A3 Multi-valent guanidinium compounds for molecular translocation across cellular membranes and epithelial tissues |
09/13/2007 | WO2007036945A3 Hepatocyte growth factor receptor splice variants and methods of using same |
09/13/2007 | WO2007030770A3 Endothelin receptors in morphine withdrawal |
09/13/2007 | WO2007028078A3 Method of repairing meniscal tears |
09/13/2007 | WO2007014179A3 Method for controlling immunodominance |
09/13/2007 | WO2007002972A3 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
09/13/2007 | WO2006130628A3 Combination of hcv protease inhibitors with a surfactant |
09/13/2007 | WO2006130607A3 Controlled-release formulation useful for treating disorders associated with hepatitis c virus |
09/13/2007 | WO2006101584A3 Cellulases, nucleic acids encoding them and methods for making and using them |
09/13/2007 | WO2006099610A3 Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy |
09/13/2007 | WO2006096487A3 Methods and compositions for modulating tweak and fn14 activity |
09/13/2007 | WO2006079107A3 Transplantation compositions and methods for treating diabetes |
09/13/2007 | WO2006074182A3 Growth factor therapy mobilization of stem cells into the peripheral blood |
09/13/2007 | WO2006052991A3 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
09/13/2007 | WO2005115439A3 Cerberus/coco derivatives and uses thereof |
09/13/2007 | WO2005074626A3 Compositions, methods and uses for a novel family of peptides |
09/13/2007 | WO2005040347A3 Methods and compositions for inhibiting cell growth and proliferation |
09/13/2007 | WO2000061614A8 Uncoupling proteins |
09/13/2007 | US20070213683 Systems, methods, and compositions for prevention of tissue adhesion |
09/13/2007 | US20070213504 Synthesis using peptide intermediate fragments |
09/13/2007 | US20070213382 2-methylthiazolidine-2, 4-dicarboxylic acid-containing combination preparations |
09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
09/13/2007 | US20070213287 Introducing nucleic acid encoding therapeutic gene product formulated with an anionic polymer selected from polyglutamic acid, polyaspartic acid, polygalacturonic acid, poly vinyl sulfate into cell |
09/13/2007 | US20070213284 Method of selecting targets for gene silencing by RNA interference |
09/13/2007 | US20070213277 Compositions and methods for enhancing drug delivery across and into ocular tissues |
09/13/2007 | US20070213276 A water soluble oligopeptide consisting of glycyl-prolyl-isoleucyl-glycyl-serine or glycyl-prolyl-isoleucyl-glycyl-threonine; hair growth-promoting effect, skin regeneration-promoting effect, therapeutic effect on skin ulcer, and therapeutic effect on mucosal injury |
09/13/2007 | US20070213275 Formulations for ecallantide |
09/13/2007 | US20070213274 Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C) |
09/13/2007 | US20070213273 Using hedgehog protein as therapeutic for treatment of bone, reproductive, nervous system and autoimmune disorders |
09/13/2007 | US20070213272 Transmucosal Administration Agent Containing Pth |
09/13/2007 | US20070213271 Composition and method for treating hiv infection |
09/13/2007 | US20070213270 Peptide yy formulations having increased stability and resistance to microbial agents |
09/13/2007 | US20070213269 Zinc finger binding domains for tnn |
09/13/2007 | US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis |
09/13/2007 | US20070213267 Peptides and Calcium Regulation in Mammalian Cells |
09/13/2007 | US20070213266 Methods for using and identifying modulators of Delta-like 4 |
09/13/2007 | US20070213265 Kunitz-type sequences and polypeptides |
09/13/2007 | US20070213264 Neuregulin variants and methods of screening and using thereof |
09/13/2007 | US20070213263 Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis |
09/13/2007 | US20070213262 Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment |
09/13/2007 | US20070213261 Asthma Preparation |
09/13/2007 | US20070213260 Novel process for the preparation of cyclosporin derivatives |
09/13/2007 | US20070213259 Method for stabilizing blood pressure in hemodialysis subjects |
09/13/2007 | US20070213258 Endotoxin adsorbent, and method for removing endotoxin using the same |
09/13/2007 | US20070213257 Compositions and methods for complexes of nucleic acids and peptides |
09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
09/13/2007 | US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes |
09/13/2007 | US20070213254 Remedy For Diabetic Neuropathy Comprising Gelatin Gel As Carrier |
09/13/2007 | US20070213253 Synuclein Mutant Having Aggregation-Inhibitory Activity |